ArticleDiagnostics (Basel, Switzerland)2024

Early CYP3A5 Genotype-Based Adjustment of Tacrolimus Dosage Reduces Risk of De Novo Donor-Specific HLA Antibodies and Rejection among CYP3A5-Expressing Renal Transplant Patients.

Kristina Schönfelder et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.